Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Molecular Insights into Breast Cancer Treatment: An Integrated Approach of Network Pharmacology and Component Analysis for Lansium parasiticum Bark Extract

Indonesian Journal of Cancer Chemoprevention · Vol. 15 No. 2 (2024) · hlm. 96–107

DOI
10.14499/indonesianjcanchemoprev15iss2pp96-107
ISSN
2355-8989, 2088-0197
Terbit
2024-06-30
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

Medicinal plants containing multi-components have the potential for multi-target genes, multi-pathways, and various effects on diverse diseases. With the increasing technological advancements, understanding the complex interactions between multi-component substances and biological systems is becoming more crucial. In this context, conventional experimental research might have limitations as it typically focuses on the impact of one component on one gene. The objective of this research is to identify compounds in the bark extract of Lansium parasiticum and elucidate the molecular mechanisms of these compounds in inhibiting the progression of breast cancer cells using a network pharmacology approach. Compound identification in Lansium parasiticum bark extract (LPBE) has been conducted using Liquid Chromatography Tandem Mass Spectrophotometry (LC-MS/MS) technique. ADMET predictions were utilized to determine the absorption and bioavailability profiles. A network pharmacology approach employing Cytoscape 3.9.1, GeneCards, Disgenet, STRING 2.0.0, SRplot, and Kyoto Encyclopedia of Genes and Genomes (KEGG) was used to predict the anti-cancer molecular mechanisms of these compounds. Seventeen active compounds have been successfully identified via LC-MS/MS. Among these, the compounds Moronic Acid, 4-Morpholineacetic Acid, and Ursolic Aldehyde were found in the highest concentrations. The results of the network pharmacology analysis indicate that the compounds in LPBE are involved in three potential pathways for breast cancer treatment: the NF-κß signaling pathway (hsa 04064), microRNA in cancer (hsa05206), and apoptosis (hsa04210). Target genes implicated in these pathways include BAX, BCL2, TNF-α, PARP1, STAT3, NOTCH1, and NF-κß1. It can be concluded that LPBE contains compounds with potential for treating breast cancer, as they are predicted to interact with relevant target pathways and genes. Therefore, further research is highly recommended, particularly in the development of drugs for breast cancer.Keywords: apoptosis, microRNA, NF-κß, TNF-α, STAT3.

Jaringan kolaborasi para penulis

28 penulis · 80 tautan kepenulisan bersama · 19 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Islam Negeri Maulana Malik Ibrahim
  • State University of Malang
  • University of Brawijaya
  • Universitas Trisakti
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Yen Yen Ari IndrawijayaState University of Malang6
Arief SuryadinataUniversitas Islam Negeri Maulana Malik Ibrahim2
Ferry SandraUniversitas Trisakti2
Farenza Okta KiranaUniversitas Islam Negeri Maulana Malik Ibrahim2
Ana RahmawatiUniversitas Islam Negeri Maulana Malik Ibrahim2
Nurlaili SusantiUniversitas Islam Negeri Maulana Malik Ibrahim2
Muhammad Ragib MustofaUniversitas Islam Negeri Maulana Malik Ibrahim2
Abdul Aziz HakimUniversitas Islam Negeri Maulana Malik Ibrahim2
Ach. NashichuddinUniversitas Islam Negeri Maulana Malik Ibrahim2
Muhammad ZainuddinUniversitas Islam Negeri Maulana Malik Ibrahim2
Tanaya Jati Dharma DewiUniversitas Islam Negeri Maulana Malik Ibrahim1
Kesimira QonitaUniversitas Islam Negeri Maulana Malik Ibrahim1
Trian Sidha MinggarwatiUniversitas Islam Negeri Maulana Malik Ibrahim1
Risma Aprinda KristantiUniversitas Islam Negeri Maulana Malik Ibrahim1
Erna SusantiAfiliasi tidak diketahui1
Ana RahmawatiAfiliasi tidak diketahui1
Jauza UlfahAfiliasi tidak diketahui1
Muhammad Firman AmrullohAfiliasi tidak diketahui1
Alif Firman FirdausyUniversitas Islam Negeri Maulana Malik Ibrahim1
Hibbatullah HibbbatullahUniversitas Islam Negeri Maulana Malik Ibrahim1
Muhammad Fawaz HarizAfiliasi tidak diketahui1
Burhan Ma’arifState University of Malang1
Ermin RachmawatiState University of Malang1
Ahmad Ulfi BaihaqiAfiliasi tidak diketahui1
Dwi PuspitaState University of Malang1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Molecular Insights into Breast Cancer Treatment: An Integrated Approach of Network Pharmacology and Component Analysis for Lansium parasiticum Bark Extract</dc:title>
	<dc:creator>Mutiah, Roihatul</dc:creator>
	<dc:creator>Annisa, Rahmi</dc:creator>
	<dc:creator>Zahiro, Syayida Roisatus</dc:creator>
	<dc:description xml:lang="en-US">Medicinal plants containing multi-components have the potential for multi-target genes, multi-pathways, and various effects on diverse diseases. With the increasing technological advancements, understanding the complex interactions between multi-component substances and biological systems is becoming more crucial. In this context, conventional experimental research might have limitations as it typically focuses on the impact of one component on one gene. The objective of this research is to identify compounds in the bark extract of Lansium parasiticum and elucidate the molecular mechanisms of these compounds in inhibiting the progression of breast cancer cells using a network pharmacology approach. Compound identification in Lansium parasiticum bark extract (LPBE) has been conducted using Liquid Chromatography Tandem Mass Spectrophotometry (LC-MS/MS) technique. ADMET predictions were utilized to determine the absorption and bioavailability profiles. A network pharmacology approach employing Cytoscape 3.9.1, GeneCards, Disgenet, STRING 2.0.0, SRplot, and Kyoto Encyclopedia of Genes and Genomes (KEGG) was used to predict the anti-cancer molecular mechanisms of these compounds. Seventeen active compounds have been successfully identified via LC-MS/MS. Among these, the compounds Moronic Acid, 4-Morpholineacetic Acid, and Ursolic Aldehyde were found in the highest concentrations. The results of the network pharmacology analysis indicate that the compounds in LPBE are involved in three potential pathways for breast cancer treatment: the NF-κß signaling pathway (hsa 04064), microRNA in cancer (hsa05206), and apoptosis (hsa04210). Target genes implicated in these pathways include BAX, BCL2, TNF-α, PARP1, STAT3, NOTCH1, and NF-κß1. It can be concluded that LPBE contains compounds with potential for treating breast cancer, as they are predicted to interact with relevant target pathways and genes. Therefore, further research is highly recommended, particularly in the development of drugs for breast cancer.Keywords: apoptosis, microRNA, NF-κß, TNF-α, STAT3.</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2024-06-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/513</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev15iss2pp96-107</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 15, No 2 (2024); 96-107</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/513/305</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Indonesian Journal of Cancer Chemoprevention</dc:rights>
</oai_dc:dc>